Pharmacological inhibition of UCH-L1 delayed recovery from AKI, while UCH-L1 overexpression accelerated tubular regeneration, highlighting its potential as a therapeutic target for promoting kidney repair [103]. This evidence concerns the gene UCHL1 and acute kidney injury.